Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)
Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for mR…
Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for mR…
Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has accepted and grante…
EMA will now initiate its centralized review procedure under accelerated assessment for Bavarian Nordic’s chikungunya va…
Bavarian Nordic A/S (OMX: BAVA) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the Eu…
- REGENERATE-PD, which is now enrolling, will study AB-1005, an adeno-associated virus 2 (AAV2) glial cell line-deriv…
New innovative therapies and diagnostics will be developed in the future at the 900 m2 MAxL - by young start-up teams. M…
MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG”, or the “Company”) - https://www.commodity-tv.com/... - announces th…
Rapid and accurate clinical diagnostic tests are essential for the detection of viral infections and proper medical care…
New partnership will harness Moderna’s mRNA rapid-response platform, clinically validated during the COVID-19 pandemic,…
Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially a…